Dihydropyridine alkanol amines, process for their preparation and pharmaceutical compositions containing them
申请人:IMPERIAL CHEMICAL INDUSTRIES PLC
公开号:EP0194751A1
公开(公告)日:1986-09-17
A
wherein R' and R2 each is alkyl, alkenyl or alkoxyalkyl, wherein R3 and R4 each is alkyl, wherein benzene ring A is unsubstituted or bears one or more additional substituents selected from halogeno, cyano, nitro, trifluoromethyl and alkyl, or bears the substituent =N-α-N= attached to the 5-and 6-positions, wherein Ar is phenyl, naphthyl, tetrahydronaphthyl, indanyl or indenyl which is unsubstituted or which bears one or more substituents, or Ar is a 5- or 6-membered heterocyclic ring containing 1, 2 or 3 heteroatoms selected from oxygen, nitrogen and sulphur, which ring is saturated or unsaturated, which ring is unsubstituted or bears one or more substituents and which ring may also be fused to a benzene ring, wherein p is 0 or 1, wherein X is -0- or -5-, and wherein Y is straight-or branched-chain alkylene or alkenylene each of 2 to 12 carbon atoms which may optionally be interrupted by one or two groups selected from oxygen, sulphur, imino, substituted imino, phenylene, substituted phenylene, pyridylene, cycloalkylene, 1,4-piperazinediyl, 1,4-piperidinediyl and amido groups; or an acid-addition salt thereof, processes for their manufacture and pharmaceutical compositions containing them. The compounds possess either beta-adrenergic blocking or calcium ion slow channel blocking properties, or both such properties, and may be used in the treatment of hypertension.
A
其中 R' 和 R2 各为烷基、烯基或烷氧基烷基,其中 R3 和 R4 各为烷基,其中苯环 A 未被取代或带有一个或多个选自卤素、氰基、硝基、三氟甲基和烷基的额外取代基、其中 Ar 是未被取代的苯基、萘基、四氢萘基、茚基或茚基,或带有一个或多个取代基,或 Ar 是含有 1、2 或 3 个选自氧、氮和硫的杂原子的 5 或 6 元杂环、其中 p 为 0 或 1,X 为-0-或-5-、其中 Y 为 2 至 12 个碳原子的直链或支链亚烷基或烯基,可任选被一个或两个选自氧、硫、亚氨基、取代亚氨基、亚苯基、取代亚苯基、吡啶基、环烷基、1,4-哌嗪二基、1,4-哌啶二基和氨基的基团打断;或其酸加成盐,以及它们的制造工艺和含有它们的药物组合物。这些化合物具有β-肾上腺素能阻断特性或钙离子慢通道阻断特性,或同时具有这两种特性,可用于治疗高血压。